Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
AI Applications for Thoracic Imaging: Considerations for Best Practice
16
Zitationen
3
Autoren
2025
Jahr
Abstract
Artificial intelligence (AI) technology is rapidly being introduced into thoracic radiology practice. Current representative use cases for AI in thoracic imaging show cumulative evidence of effectiveness. These include AI assistance for reading chest radiographs and low-dose (1.5-mSv) chest CT scans for lung cancer screening and triaging pulmonary embolism on chest CT scans. Other potential use cases are also under investigation, including filtering out normal chest radiographs, monitoring reading errors, and automated opportunistic screening of nontarget diseases. However, implementing AI tools in daily practice requires establishing practical strategies. Practical AI implementation will require objective on-site performance evaluation, institutional information technology infrastructure integration, and postdeployment monitoring. Meanwhile, the remaining challenges of adopting AI technology need to be addressed. These challenges include educating radiologists and radiology trainees, alleviating liability risk, and addressing potential disparities due to the uneven distribution of data and AI technology. Finally, next-generation AI technology represented by large language models (LLMs), including multimodal models, which can interpret both text and images, is expected to innovate the current landscape of AI in thoracic radiology practice. These LLMs offer opportunities ranging from generating text reports from images to explaining examination results to patients. However, these models require more research into their feasibility and efficacy.
Ähnliche Arbeiten
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.820 Zit.
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 · 9.942 Zit.
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 · 8.208 Zit.
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 · 6.484 Zit.
Deep Convolutional Neural Networks for Computer-Aided Detection: CNN Architectures, Dataset Characteristics and Transfer Learning
2016 · 5.731 Zit.